Still, there is limited data about modulating JAK/STAT signaling pathway in Alzheimer’s disease development; however, the possibility of simultaneously blocking a wide array of pathogenic cytokine production via inhibition of the downstream JAK/STAT pathway is becoming increasingly important. Here, SOAT1 is linked to early-onset autosomal dominant Alzheimer disease.